Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Daly

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
Microbiome|July 9, 2016
Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animalsKate L Ormerod, David L A Wood, Nancy Lachner, et al.
Archives of Internal Medicine|December 22, 1999
Thyroid carcinomas after irradiation for a first cancer during childhoodF de Vathaire, C Hardiman, A Shamsaldin, et al.
Molecular Medicine (Cambridge, Mass.)|August 11, 2016
Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis ModelSarah J Atkinson, Brian M Varisco, Mary Sandquist, et al.
International Journal of Cancer|July 15, 1998
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhoodB Le Vu, F de Vathaire, A Shamsaldin, et al.
British Journal of Cancer|April 17, 1999
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentF de Vathaire, M Hawkins, S Campbell, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
Microbiome|July 9, 2016
Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animalsKate L Ormerod, David L A Wood, Nancy Lachner, et al.
Archives of Internal Medicine|December 22, 1999
Thyroid carcinomas after irradiation for a first cancer during childhoodF de Vathaire, C Hardiman, A Shamsaldin, et al.
Molecular Medicine (Cambridge, Mass.)|August 11, 2016
Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis ModelSarah J Atkinson, Brian M Varisco, Mary Sandquist, et al.
International Journal of Cancer|July 15, 1998
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhoodB Le Vu, F de Vathaire, A Shamsaldin, et al.
British Journal of Cancer|April 17, 1999
Second malignant neoplasms after a first cancer in childhood: temporal pattern of risk according to type of treatmentF de Vathaire, M Hawkins, S Campbell, et al.
Blood|October 24, 2002
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopeniaDietmar Seiffert, Andrew M Stern, William Ebling, et al.
Blood|May 3, 2002
Evidence that thrombocytopenia observed in humans treated with orally bioavailable glycoprotein IIb/IIIa antagonists is immune mediatedJeffrey T Billheimer, Ira B Dicker, Richard Wynn, et al.
Pageof 14